Full Fed. Circ. Won't Take Up Hatch-Waxman Act Venue Limits
The full Federal Circuit shot down Valeant Pharmaceuticals' petition to rehear its challenge to a New Jersey federal judge's decision limiting where Hatch-Waxman Act patent lawsuits over generic drugs can be...To view the full article, register now.
Already a subscriber? Click here to view full article